Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Use of models to identify cost-effective interventions: pertussis vaccination for pediatric health care workers.

Greer AL, Fisman DN.

Pediatrics. 2011 Sep;128(3):e591-9. doi: 10.1542/peds.2010-0796. Epub 2011 Aug 15.

2.

Pertussis in adolescents and adults: should we vaccinate?

Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA.

Pediatrics. 2005 Jun;115(6):1675-84.

PMID:
15930232
3.

Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada.

Iskedjian M, Walker JH, Hemels ME.

Vaccine. 2004 Oct 22;22(31-32):4215-27.

PMID:
15474711
4.
5.

Cost effectiveness of pertussis vaccination in adults.

Lee GM, Murphy TV, Lett S, Cortese MM, Kretsinger K, Schauer S, Lieu TA.

Am J Prev Med. 2007 Mar;32(3):186-193.

PMID:
17296470
6.

Economic considerations for pertussis booster vaccination in adolescents.

Hay JW, Ward JI.

Pediatr Infect Dis J. 2005 Jun;24(6 Suppl):S127-33. Review.

PMID:
15931140
7.

Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.

Talbird SE, Graham J, Mauskopf J, Masseria C, Krishnarajah G.

J Manag Care Spec Pharm. 2015 Jan;21(1):88-99, 99a-c.

PMID:
25562776
8.

Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.

Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee.

MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.

9.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
10.

Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.

Terranella A, Asay GR, Messonnier ML, Clark TA, Liang JL.

Pediatrics. 2013 Jun;131(6):e1748-56. doi: 10.1542/peds.2012-3144. Epub 2013 May 27.

11.

Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Québec, Canada.

Iskedjian M, Walker JH, De Serres G, Einarson TR.

Paediatr Drugs. 2005;7(2):123-36.

PMID:
15871632
12.

Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV; Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.

13.

An economic evaluation of universal pertussis vaccination in Italy.

Beutels P, Bonanni P, Tormans G, Canale F, Crovari PC.

Vaccine. 1999 May 14;17(19):2400-9. Erratum in: Vaccine 2000 Mar 17;18(18):1970.

PMID:
10392622
16.

Cost-effectiveness of Tdap vaccination of adults aged ≥65 years in the prevention of pertussis in the US: a dynamic model of disease transmission.

McGarry LJ, Krishnarajah G, Hill G, Masseria C, Skornicki M, Pruttivarasin N, Arondekar B, Roiz J, Pelton SI, Weinstein MC.

PLoS One. 2014 Jan 9;9(1):e72723. doi: 10.1371/journal.pone.0072723. eCollection 2014.

17.

Cost-benefit analysis of hospital based postpartum vaccination with combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap).

Ding Y, Yeh SH, Mink CA, Zangwill KM, Allred NJ, Hay JW.

Vaccine. 2013 May 24;31(22):2558-64. doi: 10.1016/j.vaccine.2013.03.053. Epub 2013 Apr 12.

PMID:
23583811
18.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
19.

Rationale for the administration of acellular pertussis vaccine to parents of infants in the neonatal intensive care unit.

Shah S, Caprio M, Mally P, Hendricks-Munoz K.

J Perinatol. 2007 Jan;27(1):1-3.

PMID:
17180125
20.

Cost-effectiveness of adult pertussis vaccination in Germany.

Lee GM, Riffelmann M, Wirsing von Konig CH.

Vaccine. 2008 Jul 4;26(29-30):3673-9. doi: 10.1016/j.vaccine.2008.04.068. Epub 2008 May 19.

PMID:
18538901
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk